Loddenkemper Tobias, Morris Harold H, Lineweaver Tara T, Kellinghaus Christoph
Department of Neurology, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Epilepsia. 2007 Mar;48(3):553-8. doi: 10.1111/j.1528-1167.2007.00982.x. Epub 2007 Feb 21.
Our goal was to determine the frequency of repeated intracarotid amobarbital test (IAT) at our center and to estimate the retest reliability of the IAT for both language and memory lateralization.
A total of 1,249 consecutive IATs on 1,190 patients were retrospectively reviewed for repeat tests.
In 4% of patients the IAT was repeated in order to deliver satisfactory information on either language or memory lateralization. Reasons for repetition included obtundation and inability to test for memory lateralization, inability to test for language lateralization, no hemiparesis during first test, no aphasia during first test, atypical vessel filling, and bleeding complications from the catheter insertion site. Language lateralization was reproduced in all but one patient. Repeated memory test results were less consistent across tests, and memory lateralization was unreliable in 63% of the patients.
In spite of test limitations by a varying dose of amobarbital, crossover of amobarbital from one side to the other, testing of both hemispheres on the same day, practice effects, unblinded observers, fluctuating cooperation of the patients, and a biased sample of patients language lateralization was reproduced in all but one patient. In contrast, repeated memory test results were frequently contradictory. Memory results on IAT therefore seem much less robust than the results of language testing. Gain of reliable information versus the risks of complications and failed tests has to be considered when a patient is subjected to an IAT.
我们的目标是确定在我们中心重复进行颈内动脉阿米妥试验(IAT)的频率,并评估IAT在语言和记忆定侧方面的复测可靠性。
对1190例患者连续进行的1249次IAT进行回顾性分析,以确定重复试验情况。
4%的患者重复进行了IAT,以便获得关于语言或记忆定侧的满意信息。重复的原因包括意识模糊和无法进行记忆定侧测试、无法进行语言定侧测试、首次测试时无偏瘫、首次测试时无失语、血管充盈异常以及导管插入部位的出血并发症。除1例患者外,所有患者的语言定侧结果均可重现。重复记忆测试结果在不同测试之间的一致性较差,63%的患者记忆定侧结果不可靠。
尽管存在不同剂量的阿米妥、阿米妥从一侧交叉到另一侧、同一天对双侧半球进行测试、练习效应、观察者未设盲、患者合作程度波动以及患者样本存在偏差等测试局限性,但除1例患者外,所有患者的语言定侧结果均可重现。相比之下,重复记忆测试结果经常相互矛盾。因此,IAT的记忆结果似乎远不如语言测试结果可靠。当对患者进行IAT时,必须考虑获得可靠信息与并发症风险和测试失败之间的权衡。